David D. O'Toole Net Worth & Insider Trades

David D. O'Toole - Chief Financial Officer, Opiant Pharmaceuticals, Inc

As of July 15, 2022

What is David D. O'Toole's Net Worth?

The current estimated net worth of Opiant Pharmaceuticals, Inc's Chief Financial Officer, David D. O'Toole, is estimated to be about $1.39M . David D. O'Toole owns about 36,804 units of Opiant Pharmaceuticals, Inc common stock. In the last 5 years at Opiant Pharmaceuticals, Inc, David D. O'Toole has sold an estimated value of $21.87K worth.

What is David D. O'Toole's Past Insider Trading?

David D. O'Toole's largest purchase order was 3,000 units , worth over $56.55K on May 14, 2018. David D. O'Toole's largest sale order was 432 units , worth over $13.22K on January 12, 2022. In total, David D. O'Toole has made about 20 transactions over 5 years of their time at Opiant Pharmaceuticals, Inc. David D. O'Toole usually trades in January, with the busiest year in 2019. The most recent transaction was a sale order of 779 units , worth over $8.65K on July 15, 2022.

David D. O'Toole

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David D. O'Toole's' Mailing Address?

  • Mailing address is 1640 Marengo Street Los Angeles CA 90033 CA

What are Opiant Pharmaceuticals, Inc's Past Insider Trades?

Opiant Pharmaceuticals, Inc's most recent insider trade came on July 21, 2022 by Matthew Ruth who sold 1,084 units worth $11.51K . In the last 5 years, insiders at Opiant Pharmaceuticals, Inc have sold an estimated value of $13.37M and bought an estimated value of $11.56M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Phil Skolnick, Chief Scientific Officer,  David D. O'Toole, Chief Financial Officer,  and Roger Crystal, Chief Executive Officer .

OPIANT PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1